Global Weight Loss and Obesity Management Market Size, Status and Forecast 2019-2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Weight Loss and Obesity Management Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Weight Loss and Obesity Management Devices
- 1.4.3 Weight Loss and Obesity Management Drugs
- 1.5 Market by Application
- 1.5.1 Global Weight Loss and Obesity Management Market Share by Application (2014-2025)
- 1.5.2 Men
- 1.5.3 Women
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Weight Loss and Obesity Management Market Size
- 2.2 Weight Loss and Obesity Management Growth Trends by Regions
- 2.2.1 Weight Loss and Obesity Management Market Size by Regions (2014-2025)
- 2.2.2 Weight Loss and Obesity Management Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Weight Loss and Obesity Management Market Size by Manufacturers
- 3.1.1 Global Weight Loss and Obesity Management Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Weight Loss and Obesity Management Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Weight Loss and Obesity Management Market Concentration Ratio (CR5 and HHI)
- 3.2 Weight Loss and Obesity Management Key Players Head office and Area Served
- 3.3 Key Players Weight Loss and Obesity Management Product/Solution/Service
- 3.4 Date of Enter into Weight Loss and Obesity Management Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Weight Loss and Obesity Management Market Size by Type (2014-2019)
- 4.2 Global Weight Loss and Obesity Management Market Size by Application (2014-2019)
5 United States
- 5.1 United States Weight Loss and Obesity Management Market Size (2014-2019)
- 5.2 Weight Loss and Obesity Management Key Players in United States
- 5.3 United States Weight Loss and Obesity Management Market Size by Type
- 5.4 United States Weight Loss and Obesity Management Market Size by Application
6 Europe
- 6.1 Europe Weight Loss and Obesity Management Market Size (2014-2019)
- 6.2 Weight Loss and Obesity Management Key Players in Europe
- 6.3 Europe Weight Loss and Obesity Management Market Size by Type
- 6.4 Europe Weight Loss and Obesity Management Market Size by Application
7 China
- 7.1 China Weight Loss and Obesity Management Market Size (2014-2019)
- 7.2 Weight Loss and Obesity Management Key Players in China
- 7.3 China Weight Loss and Obesity Management Market Size by Type
- 7.4 China Weight Loss and Obesity Management Market Size by Application
8 Japan
- 8.1 Japan Weight Loss and Obesity Management Market Size (2014-2019)
- 8.2 Weight Loss and Obesity Management Key Players in Japan
- 8.3 Japan Weight Loss and Obesity Management Market Size by Type
- 8.4 Japan Weight Loss and Obesity Management Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Weight Loss and Obesity Management Market Size (2014-2019)
- 9.2 Weight Loss and Obesity Management Key Players in Southeast Asia
- 9.3 Southeast Asia Weight Loss and Obesity Management Market Size by Type
- 9.4 Southeast Asia Weight Loss and Obesity Management Market Size by Application
10 India
- 10.1 India Weight Loss and Obesity Management Market Size (2014-2019)
- 10.2 Weight Loss and Obesity Management Key Players in India
- 10.3 India Weight Loss and Obesity Management Market Size by Type
- 10.4 India Weight Loss and Obesity Management Market Size by Application
11 Central & South America
- 11.1 Central & South America Weight Loss and Obesity Management Market Size (2014-2019)
- 11.2 Weight Loss and Obesity Management Key Players in Central & South America
- 11.3 Central & South America Weight Loss and Obesity Management Market Size by Type
- 11.4 Central & South America Weight Loss and Obesity Management Market Size by Application
12 International Players Profiles
- 12.1 Novo Nordisk
- 12.1.1 Novo Nordisk Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Weight Loss and Obesity Management Introduction
- 12.1.4 Novo Nordisk Revenue in Weight Loss and Obesity Management Business (2014-2019)
- 12.1.5 Novo Nordisk Recent Development
- 12.2 GlaxoSmithKline
- 12.2.1 GlaxoSmithKline Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Weight Loss and Obesity Management Introduction
- 12.2.4 GlaxoSmithKline Revenue in Weight Loss and Obesity Management Business (2014-2019)
- 12.2.5 GlaxoSmithKline Recent Development
- 12.3 Roche
- 12.3.1 Roche Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Weight Loss and Obesity Management Introduction
- 12.3.4 Roche Revenue in Weight Loss and Obesity Management Business (2014-2019)
- 12.3.5 Roche Recent Development
- 12.4 Allergan
- 12.4.1 Allergan Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Weight Loss and Obesity Management Introduction
- 12.4.4 Allergan Revenue in Weight Loss and Obesity Management Business (2014-2019)
- 12.4.5 Allergan Recent Development
- 12.5 Johnson & Johnson
- 12.5.1 Johnson & Johnson Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Weight Loss and Obesity Management Introduction
- 12.5.4 Johnson & Johnson Revenue in Weight Loss and Obesity Management Business (2014-2019)
- 12.5.5 Johnson & Johnson Recent Development
- 12.6 Medtronic
- 12.6.1 Medtronic Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Weight Loss and Obesity Management Introduction
- 12.6.4 Medtronic Revenue in Weight Loss and Obesity Management Business (2014-2019)
- 12.6.5 Medtronic Recent Development
- 12.7 Vivus Inc
- 12.7.1 Vivus Inc Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Weight Loss and Obesity Management Introduction
- 12.7.4 Vivus Inc Revenue in Weight Loss and Obesity Management Business (2014-2019)
- 12.7.5 Vivus Inc Recent Development
- 12.8 Eisai
- 12.8.1 Eisai Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Weight Loss and Obesity Management Introduction
- 12.8.4 Eisai Revenue in Weight Loss and Obesity Management Business (2014-2019)
- 12.8.5 Eisai Recent Development
- 12.9 Nalpropion Pharmaceuticals
- 12.9.1 Nalpropion Pharmaceuticals Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Weight Loss and Obesity Management Introduction
- 12.9.4 Nalpropion Pharmaceuticals Revenue in Weight Loss and Obesity Management Business (2014-2019)
- 12.9.5 Nalpropion Pharmaceuticals Recent Development
- 12.10 ReShape Lifesciences
- 12.10.1 ReShape Lifesciences Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Weight Loss and Obesity Management Introduction
- 12.10.4 ReShape Lifesciences Revenue in Weight Loss and Obesity Management Business (2014-2019)
- 12.10.5 ReShape Lifesciences Recent Development
- 12.11 Obalon Therapeutics
- 12.12 Allurion Technologies
- 12.13 Beijing Noble Laser Technology
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
In 2018, the global Weight Loss and Obesity Management market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Weight Loss and Obesity Management status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Weight Loss and Obesity Management development in United States, Europe and China.
The key players covered in this study
Novo Nordisk
GlaxoSmithKline
Roche
Allergan
Johnson & Johnson
Medtronic
Vivus Inc
Eisai
Nalpropion Pharmaceuticals
ReShape Lifesciences
Obalon Therapeutics
Allurion Technologies
Beijing Noble Laser Technology
Market segment by Type, the product can be split into
Weight Loss and Obesity Management Devices
Weight Loss and Obesity Management Drugs
Market segment by Application, split into
Men
Women
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Weight Loss and Obesity Management status, future forecast, growth opportunity, key market and key players.
To present the Weight Loss and Obesity Management development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Weight Loss and Obesity Management are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.